Probiotics, prebiotics, digestive enzymes, fiber supplements, and synbiotics all occupy the gut health space — and all face the same fundamental compliance challenge: the gut microbiome is implicated in so many health conditions that almost any claim about gut function can be read as a disease claim if it's not carefully framed.
What FDA Permits for Gut and Digestive Claims
Under 21 CFR 101.93(f), supplement labels may describe how ingredients affect the structure or function of the digestive system and the microbiome. These are permitted:
"Supports healthy digestion"
"Promotes a healthy gut microbiome"
"Helps maintain healthy gut flora"
"Supports the balance of beneficial bacteria in the gut"
"Promotes healthy bowel regularity"
"Supports digestive comfort"
"Promotes nutrient absorption"
"Supports healthy intestinal function"
These claims describe normal digestive function in healthy individuals. They don't reference disease states or imply treatment of digestive disorders.
Where Gut Health Claims Cross the Line
Prohibited disease claims in the gut health category:
"Treats irritable bowel syndrome (IBS)" — named disease
"Relieves symptoms of Crohn's disease" — named inflammatory bowel disease
"Reduces bloating caused by lactose intolerance" — references a medical condition
"Helps with leaky gut syndrome" — while contested as a medical diagnosis, marketing products specifically for this condition implies treatment of a disease state
"Treats small intestinal bacterial overgrowth (SIBO)" — named condition
"Helps with antibiotic-associated diarrhea" — references a specific clinical context
"Reduces colorectal cancer risk" — authorized health claims for fiber and cancer risk exist under specific circumstances, but general claims about cancer prevention are not structure/function claims
The regularity problem
"Promotes healthy bowel regularity" is a structure/function claim. "Relieves constipation" is a disease claim — constipation is a defined medical condition with its own diagnosis and treatment landscape. This is one of the most common misframings in fiber and probiotic marketing.
The Gut-Brain Axis: An Emerging Compliance Risk
Emerging research on the gut-brain axis has led some brands to make claims connecting gut health supplements to mood, cognition, and stress. These claims carry compounded risk: they implicate both the digestive system and the brain, and any reference to treating anxiety, depression, or cognitive impairment in the context of gut health is a disease claim for both conditions simultaneously.
"Supports a healthy gut-brain connection" may be defensible as a structure/function claim. "Improves mood by supporting gut health" crosses into disease territory if "improves mood" is read as implying treatment of mood disorders — which the FDA can find under 21 CFR 101.93(g)(2)(ii).
CFU Claims and Labeling Accuracy
Probiotic products commonly make claims about CFU (colony-forming unit) counts — "10 billion CFUs per serving." These are quantitative claims that must be accurate at the time of consumption, not just at the time of manufacture. Probiotics degrade over time, particularly under poor storage conditions.
If the CFU count on your label reflects the count at manufacture and the product's CFU count drops significantly before the expiration date, the label claim may be inaccurate — which creates misbranding exposure independent of any structure/function claim issue.
Probiotic Strain Specificity
Research on probiotic effects is typically strain-specific. Evidence for one Lactobacillus strain doesn't necessarily transfer to another strain of the same species. Under 21 CFR 101.93(a)(3), the substantiation requirement applies to the specific claim you're making for the specific ingredients in your product.
Citing evidence for Lactobacillus rhamnosus GG to substantiate a claim for a different Lactobacillus strain is a substantiation problem — not just a scientific accuracy problem. If your product's 30-day structure/function notification certifies that you have substantiation for a claim, that substantiation needs to apply to what's actually in your product.
The gut health category rewards claim precision
The brands that navigate gut health compliance successfully are the ones that understand the specific claims they're making, the specific evidence they have for each ingredient, and where the line is between describing normal digestive function and implying treatment of digestive disease. Truli cross-references your gut health claims against your product formulation and flags anything that crosses into prohibited territory — before your label goes to print or your website goes live.
A note from Truli: Truli is not a law firm, and this article does not constitute or contain legal advice or create an attorney-client relationship. When determining your obligations and compliance with respect to relevant laws and regulations, you should consult a licensed attorney.
